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Abstract 
Pinitkiatisakul, S. 2007. Recombinant subunit vaccines against Neospora caninum.  
Doctoral thesis. 
ISSN 1652-6880, ISBN 978-91-576-7339-8 
 
The intracellular protozoan parasite Neospora caninum is an important cause of bovine 
abortion and congenital infection in many countries. Currently there is no effective control 
method available, and development of a vaccine has been suggested as a possible strategy to 
prevent the disease neosporosis. 
In this thesis an experimental recombinant subunit vaccine, consisting of the N. caninum 
antigen NcSRS2 and immunostimulating complexes (iscoms), was evaluated. The iscom is 
an adjuvant formulation into which antigens can be incorporated by hydrophobic 
interactions. Many recombinant proteins are hydrophilic, and special methods are needed 
for binding them to the iscoms and to achieve optimal adjuvant effects. 
A novel method to combine recombinant proteins with iscoms utilizing the strong 
interaction between biotin and streptavidin was evaluated. Recombinant NcSRS2 was 
expressed in Escherichia coli as two different fusion proteins. One of them was biotinylated 
in E. coli and was bound to streptavidin-coated iscom matrix (iscom particles without any 
antigen). The other fusion protein contained recombinant streptavidin and was bound to 
biotinylated iscom matrix. These two strategies both resulted in efficient binding to the 
iscom matrix. Thus, this method might offer a convenient and effective alternative for 
association of other hydrophilic recombinant antigens with iscoms for evaluation in 
immunisation experiments. 
Both the immunogenicity and the protective effect of the NcSRS2-iscoms were 
investigated by immunisation and challenge infection of mice. A real-time PCR assay was 
developed, and used for quantification of parasite DNA in the brain and blood of infected 
mice.  
The NcSRS2-iscoms induced production of antibodies that recognised NcSRS2 of 
parasite origin, suggesting that the conformation of the recombinant protein was similar to 
that of the native antigen. Antigen-specific cellular responses were also induced as 
demonstrated by in vitro proliferation and cytokine production. After challenge infection, 
the immunised mice had significantly lower levels of N. caninum DNA in their brains and 
blood than did non-immunised control mice. These mice were also less affected by the 
disease, as judged by clinical symptoms and changes in body weight. These results, together 
with results from other studies, indicate that recombinant NcSRS2 might be considered as a 
potential candidate antigen for a future subunit vaccine against N. caninum infection in 
cattle. 
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Abbreviations 
ABP  albumin binding protein 
Bio  biotin / biotinylated  
Bio-matrix  biotinylated iscom matrix 
BioSRS2’-iscom(Ni) Ni
2+-matrix + His6-SA + Bio-His6-ABP-SRS2’ 
Con A  concanavalin A 
cpm  counts per minute 
Ct cycle  threshold 
dBioSRS2’-iscom(Ni) Ni
2+-matrix + His6-SA + Bio-Bio-His6-ABP-SRS2’ 
DNA deoxyribonucleic  acid 
E. coli  Escherichia coli 
ELISA enzyme-linked  immunosorbent  assay 
His6 hexahistidyl 
HRP horse-radish  peroxidase 
IDA-matrix  matrix containing the chelating lipid IDA-Trig-DSGE 
IFN- interferon  gamma 
Ig immunoglobulin 
IL interleukin 
Iscom immunostimulating  complex 
KD  dissociation equilibrium constant 
kDa kilodalton 
M5  peptide derived from the Plasmodium falciparum blood- 
   stage  antigen  Pfl55/RESA 
M5-iscom(Ni) Ni
2+-matrix + His6-SA + Bio-His6-ABP-M5 
matrix iscom  matrix  i.e. iscom particles without any antigen 
NCDG, NcGRA  dense granule antigen of N. caninum 
NcMIC  microneme antigen of N. caninum 
NcSAG1  surface antigen 1 of N. caninum 
NcSRS2  SAG1 related sequences 2 of N. caninum 
N. caninum  Neospora caninum 
NK natural  killer  cell 
PCR polymerase  chain  reaction 
Quil A  saponin derived from Quillaja saponaria Molina 
SA streptavidin 
SA-SRS2’-iscom(Bio) Biotin-matrix  +  His6-SA-SRS2’ 
SA-SRS2’-iscom(Ni) Ni
2+-matrix + His6-SA-SRS2’ 
SDS-PAGE  sodium dodecyl sulfate-polyacrylamide gel  
 electrophoresis 
T. gondii  Toxoplasma gondii 
TgSAG1  surface antigen 1 of T. gondii 
TgSRS2  SAG1 related sequences 2 of T. gondii 
Th1 type  1  T-helper 
Th2 type  2  T-helper 
TNF-  tumor necrosis factor-alpha 
ZZM5  recombinant protein containing two IgG-binding domains  
  of the staphylococcal protein A as fusion partner to M5  9  
Background 
The protozoan parasite Neospora caninum is an important cause of abortion in 
cattle (the intermediate host), as well as causing paralysis in dogs (the definitive 
host). At present there is no efficient vaccine available against the disease 
neosporosis. This thesis investigates an experimental vaccine consisting of a 
recombinant  N. caninum protein (NcSRS2) and immuno-stimulating complexes 
(iscoms) as adjuvant. A mouse model is used to evaluate a novel method of 
combining recombinant proteins with this kind of adjuvant.  
 
Neospora caninum 
Neospora caninum is an intracellular coccidian parasite closely related to 
Toxoplasma gondii, and placed in the family Sarcocystidae of the phylum 
Apicomplexa. N. caninum causes neosporosis, which affects both cattle and dogs. 
Today, it is recognised as a major cause of bovine abortion and neonatal mortality 
worldwide, and neosporosis is considered to be economically important to the 
farming industry (Dubey, 1999a; Dubey & Lindsay, 1996; Hemphill, 1999). The 
parasite was originally described in 1984 as an unidentified cyst-forming 
sporozoon causing encephalitis and myositis in dogs (Bjerkås, Mohn & Presthus, 
1984). Later, Dubey and coworkers identified a similar parasite causing 
neuromuscular disease in dogs, and proposed the genus Neospora and species N. 
caninum (Dubey et al., 1988a; Dubey et al., 1988b). The complete lifecycle, 
including the dog as a definitive host, was described by McAllister and coworkers 
(McAllister et al., 1998). Recently, the coyote has also been identified as a 
definitive host (Gondim et al., 2004).  
 
Parasite stages 
N. caninum is an obligate intracellular parasite with a life cycle comprising three 
infectious stages: tachyzoites, bradyzoites within tissue cysts, and sporozoites 
within oocysts. Tachyzoites and bradyzoites are intracellular, asexual stages of the 
parasite found in both intermediate and definitive hosts. Oocysts are shed by the 
definitive host after sexual reproduction in its intestine (Dubey et al., 2002). 
 
The tachyzoites are ovoid, lunate or globular and 3–7 x 1–5 m in size. They 
have been detected in various host tissues or cell types, including macrophages, 
fibroblasts, vascular endothelial cells, myocytes and hepatocytes, but mostly in the 
brain and spinal cord (Dubey & Lindsay, 1996). This ability to infect a wide range 
of cells implies that N. caninum has a low host-cell specificity (Hemphill et al., 
1999). The individual infected host cells may each contain many tachyzoites, 
located within a parasitophorous vacuole in the host-cell cytoplasm (Dubey et al., 
2002). They proliferate into two zoites by a process called endodyogeny (internal 
budding), producing hundreds of new tachyzoites within a few days after infection, 
resulting in cell lysis and necrosis. The new parasites that are released can invade 
nearby cells or be transported by blood or lymph to other organs (Dubey & 
Lindsay, 1996).   10
The bradyzoites are slender and elongate with a subterminal nucleus, 
approximately 8 x 2 m in size and located in tissue cysts. Tissue cysts are often 
round to oval in shape, up to 100 m long, with a smooth cyst wall 1–4 m thick, 
depending on how long the infection has existed (Dubey et al., 2002). Most tissue 
cysts are found in the central nervous system and other neural tissues, including 
retina and peripheral nerves (Daft et al., 1997; Dubey, 1999a; Dubey et al., 1988a; 
Dubey & Lindsay, 1996). 
 
The oocysts, which are the result of the sexual phase of the life cycle, are 
spherical to subspherical in shape and approximately 11 m in diameter (Dubey, 
1999a; Lindsay, Upton & Dubey, 1999b). The oocyst wall is colourless and 0.6–
0.8  m thick. Sporulated oocysts contain two sporocysts with four sporozoites 
within. Oocysts of N. caninum are morphologically indistinguishable from those of 
Hamondia heydorni, found in canid faeces, and T. gondii, found in felid faeces 
(Dubey, 1999a). 
 
Life cycle 
N. caninum can infect a wide range of animal species that can serve as 
intermediate hosts. Natural infection has been recorded in cattle, sheep, goats, 
horses, deer and dogs. In addition, mice, rats, dogs, foxes, cats, coyotes, pigs, 
gerbils and rabbits have been experimentally infected (Dubey & Lindsay, 1996). 
Dogs and coyotes can act as both intermediate and definitive hosts; and after 
ingestion of tissue cysts in, for example, bovine placenta they can shed oocysts in 
their faeces (Dijkstra et al., 2001; Gondim et al., 2004; McAllister et al., 1998). 
The oocysts sporulate and become infective within 24 hours (Lindsay, Dubey & 
Duncan, 1999a). 
 
There are two main modes of transmission of N. caninum (Fig. 1): postnatal or 
horizontal transmission through ingestion of oocysts or tissue cysts, and 
transplacental or vertical transmission from an infected mother to her foetus. In 
cattle, vertical tranmission is the dominant route of infection, and can occur 
repeatedly in consecutive pregnancies (Barr et al., 1993; Barr et al., 1994b; 
Thurmond & Hietala, 1997). Experimentally, transplacental transmission has been 
induced in several other species, e.g. dogs (Cole et al., 1995a; Dubey & Lindsay, 
1989a; Dubey & Lindsay, 1989b), cats (Dubey & Lindsay, 1989b), mice (Cole et 
al., 1995b; Long & Baszler, 1996), sheep (Buxton et al., 1997; McAllister et al., 
1996), goats (Lindsay et al., 1995b), pigs (Jensen et al., 1998) and non-human 
primates (Barr et al., 1994a). 
 
It has been suggested that an additional mode of vertical transmission could be 
via the colostrum, since neonatal calves have been experimentally infected by 
feeding them colostrum containing tachyzoites (Uggla et al., 1998). Recently, 
parasite DNA has been demonstrated in colostrum from seropositive cows, 
implicating the possibility of transmission through colostra. However, it is 
uncertain if this occurs naturally, as high levels of specific antibodies in the 
colostrum might neutralise the infectivity of tachyzoites (Davison et al., 2001; 
Moskwa et al., 2007).  11 
There are many aspects of the life cycle of N. caninum that are still unknown, 
including the survival of oocysts in the environment, frequency of oocyst shedding 
and whether canids other than the domestic dog and the coyote can act as 
definitive host. Moreover, the entero-epithelial stages of N. caninum, preceding 
oocyst formation in dogs, have not been described yet. 
 
It was previously reported that Neospora infection might not be a zoonotic threat 
to healthy humans (Petersen et al., 1999); however, it might possibly cause disease 
in immunocompromised patients, as specific antibody to N. caninum have been 
detected in sera from such individuals (Lobato et al., 2006). 
 
 
 
Fig. 1. The life cycle of Neospora caninum. The dog is a definitive host of the parasite, and 
can shed oocysts with its faeces. Oocysts can be ingested by intermediate hosts, such as the 
cow. Tachyzoites may be transmitted from the dam to her foetus. This is the main form of 
transmission for the parasite. The dog may ingest tissue cysts via uncooked tissue from an 
intermediate host, thus completing the life cycle of the parasite. Modified from a figure 
published in Veterinary Parasitology 84 (1999) with kind permission from J.P Dubey.   12
Neosporosis in cattle 
N. caninum is a major cause of abortion in both dairy (Dubey & Lindsay, 1996) 
and beef (Hoar et al., 1996; Waldner, Janzen & Ribble, 1998) cattle, as reported 
from many countries over the world, including U.S.A., Canada, New Zealand, 
Australia, and several countries in Europe, Asia and Africa (Dubey, 1999a; Dubey, 
1999b; Dubey & Lindsay, 1996; Hemphill & Gottstein, 2000). 
 
Abortion is the only clinical sign observed in adult cows. It can occur from 3 
months gestation to term, and most commonly occurs at 5–6 months gestation. 
Neosporosis-induced abortion happens throughout the year (Dubey, 2003). It may 
be epidemic, endemic or sporadic. It has been shown that N. caninum-seropositive 
cows are more likely to abort than are seronegative cows (Atkinson et al., 2000; 
Jensen et al., 1999; Moen et al., 1998; Pfeiffer et al., 2002; Thurmond, Hietala & 
Blanchard, 1997; Wouda, Moen & Schukken, 1998). The consequences of 
infection in a pregnant cow can be foetal death with resorption or mummification, 
autolysis or abortion of the foetus, a stillborn calf, birth of a clinically weak calf, 
or birth of a clinically healthy but congenitally chronically infected calf. Because 
vertical transmission can occur repeatedly in consecutive pregnancies (Barr et al., 
1993; Thurmond & Hietala, 1997), and congenitally infected heifers can transfer 
the parasite to their progeny, the parasite can persist in an infected herd for many 
years without involvement of a definitive host (Björkman et al., 1996). 
 
Clinical symptoms in calves congenitally infected with N. caninum include: 
neurological signs, an inability to rise, underweight, flexed or hyper-extended 
hindlimbs and/or forelimbs, ataxia, decreased patellar reflexes, and loss of 
conscious proprioception (Dubey, 1999a; Dubey, 2003). 
 
Neosporosis is considered to be a costly disease for the cattle industry. In 
addition to the direct costs due to abortion, increased culling of affected cows and 
reduction of female breeding cattle, indirect costs should be considered, including 
diagnostic costs, milk yield loss, professional help expenses, and replacement costs 
for culled cows. In California the direct cost for Neospora-induced abortion was 
estimated to be $US35 million per year (Dubey, 1999b). In a recent study the 
annual costs for the dairy industry due to neosporosis in Australia and New 
Zealand was estimated to $AU 21 million and $NZ 28, respectively (Reichel & 
Ellis, 2006). In Switzerland, losses attributed to N. caninum in the dairy industry 
was estimated to be approximately $US12.8 million annually (Häsler et al., 2006). 
 
Presently, there are no effective methods to control N. caninum infections in 
cattle. Since the main route of infection is vertical transmission, from a dam to her 
foetus for several generations (Anderson et al., 1997; Björkman et al., 1996; 
Schares et al., 1998), culling of infected animals may be an appropriate practice to 
control the disease in a herd (French et al., 1999; Thurmond & Hietala, 1995). But 
this is not feasible if a large proportion of the animals is infected. Also, this will 
result in a non-immune herd, and if there is a risk of horizontal infection, for 
example by oocyst excretion from dogs, problems can arise. 
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To prevent horizontal transmission, dogs, coyotes or other potential definitive 
hosts should be prevented from contaminating cattle feed or water. Also, 
appropriate measures should be established to remove aborted bovine foetuses, 
foetal membranes, placentas and dead calves from infected cows (Innes et al., 
2000). However, there is no evidence of horizontal transmission between cows 
(Anderson et al., 1997). 
 
Embryo transfers from seropositive cows to seronegative recipients has been 
shown to result in the birth of uninfected calves, and can be used as a method of 
disease control (Baillargeon et al., 2001; Landmann et al., 2002).  
 
Various chemotherapies have been tested in vitro (Dubey & Lindsay, 1996; Kim 
et al., 2002; Lindsay, Butler & Blagburn, 1997) or in vivo in a mouse model 
(Gottstein et al., 2001) and in cattle (Kritzner et al., 2002). However, to date there 
are no known antimicrobial agents that can completely clear the parasites from 
chronically infected animals. 
 
Neosporosis in dogs 
Dogs can be both intermediate and definitive hosts (Dubey, 1999a). Antibodies to 
N. caninum have been demonstrated in dogs in several countries throughout the 
world (Dubey, 1999a; Dubey & Lindsay, 1996). Neosporosis is now recognised as 
an important cause of fatal disease in young as well as old dogs. However, the 
most severe cases of neosporosis occur in young, congenitally infected pups 
(Dubey, 1999a). Canine neosporosis has been reported from many countries 
(Dubey & Lindsay, 1996). Dogs with clinical neosporosis show hind-limb paresis 
that develops into a progressive paralysis and other neurological signs, myositis, 
pneumonia, and dermatitis (Barber & Trees, 1996; Dubey et al., 1988b; 
Ruehlmann et al., 1995). Other neurological signs include: forelimb ataxia, head 
tremors with tetraparesis, and rigid hyperextension of both hind and front limbs 
(although the hind limbs are more often affected than the forelimbs) (Barber & 
Trees, 1996; Pasquali et al., 1998). Other dysfunctions which might be observed 
include: paralysis of the jaw, difficulty in swallowing, muscle atrophy, muscle 
flaccidity, and sudden collapse due to myocarditis and heart failure (Barber & 
Trees, 1996; Dubey & Lindsay, 1996). 
 
Antimicrobial drugs, including clindamycin, sulfonamides and pyrimethamine, 
have been used in dogs with clinical neosporosis (Barber & Trees, 1996; Dubey et 
al., 1998; Dubey et al., 1995; Mayhew et al., 1991; McGlennon, Jefferies & Casas, 
1990). For example, ten of 16 dogs with demonstrated neosporosis partially 
recovered when treated with these drugs (Barber & Trees, 1996). Also, in a dog 
with neosporosis-associated dermatitis no viable N. caninum could be 
demonstrated after prolonged clindamycin therapy (Dubey et al., 1995). However, 
the recovery rate of treated dogs may be less in cases with severe neosporosis 
(Barber & Trees, 1996; Dubey et al., 1998). 
   14
Neosporosis in mice 
The mouse is frequently used as a laboratory-animal model to investigate the 
biology of N. caninum, immune responses to the parasite, and the effect of 
antimicrobial drug therapy. 
 
Several inbred and outbred mouse strains have been used to study N. caninum 
infection. N. caninum is more or less non-pathogenic to outbred Swiss Webster 
mice, and the infection only occasionally establishes as tissue cysts in those mice 
(Dubey et al., 1988b; Lindsay & Dubey, 1989a). However, in cortisonised outbred 
mice tissue cysts develop more often (Lindsay & Dubey, 1989a; McGuire, 
McAllister & Jolley, 1997). Inbred BALB/c mice are more susceptible to N. 
caninum infection than are outbred mice, and clinical neosporosis can be observed 
2–3 weeks after parasite inoculation (Lindsay et al., 1995a). Typical symptoms are 
head tilting, circling, hind limb paralysis, and progressive weakness. However, the 
severity of the clinical symptoms depends on the isolate, dose and number of 
passages in cell culture of N. caninum (Atkinson et al., 1999; Bartley et al., 2006; 
Lindsay et al., 1995a). The main pathological lesion is meningoencephalitis 
(Lindsay & Dubey, 1990). Congenital transmission occurs in BALB/c mice after 
inoculation with tachyzoites during pregnancy (Long & Baszler, 1996). 
 
In addition, severe clinical neosporosis can be induced by experimental infection 
of immunosuppressed and immunodeficient mice, such as: mice treated with 
methylprednisolone acetate (Lindsay & Dubey, 1989a; Lindsay & Dubey, 1990; 
Lindsay et al., 1995a), athymic nude mice (Yamage, Flechtner & Gottstein, 1996), 
mice treated with antibody against interferon gamma (IFN-) (Khan et al., 1997), 
and IFN- knockout mice (McAllister et al., 1998). 
 
Diagnosis 
Serology and immunoblotting 
Demonstration of antibodies to N. caninum in the serum from an animal indicates 
that it is, or has previously been, exposed to the parasite. Antibodies can be 
demonstrated by the indirect fluorescent antibody test (IFAT) (Dubey et al., 
1988b), the direct agglutination test (Neospora agglutination test; NAT) (Packham 
et al., 1998; Romand, Thulliez & Dubey, 1998), and enzyme-linked 
immunosorbent assay (ELISA) (Björkman, Holmdahl & Uggla, 1997; Pare, 
Hietala & Thurmond, 1995). To discriminate between recent and chronic N. 
caninum infection, an IgG avidity ELISA has been developed and applied for 
bovine samples (Björkman et al., 1999). Since immunoblotting analysis has high 
specificity, it has been used as a confirmatory test in several studies of different 
animal species (Jakubek, Lundén & Uggla, 2006; Staubli et al., 2006; Vardeleon et 
al., 2001). 
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Histological examination and immunohistochemistry  
N. caninum can cause histopathological changes in various tissues, but the most 
commonly affected tissues are the brain, heart and skeletal muscle (Barr et al., 
1991; Dubey et al., 1988a; Lindsay et al., 1995a). These tissues can be sectioned 
and stained using routine histological techniques with hematoxylin and eosin. The 
histopathological changes are degenerative inflammatory lesions found in those 
organs. However, the main histopathological lesions of neosporosis are found in 
infected brain tissue, and consist of focal, nonsuppurative encephalitis and a 
variable number of focal necroses (Dubey, 2003; Dubey & Lindsay, 1996). In 
neosporosis, there is no pathognomonic histological or gross lesion. The 
histopathological lesions could lead to a presumptive diagnosis (Dubey, 1999a), 
but other diagnostic methods, e.g. immunohistochemistry, serology and detection 
of N. caninum DNA, are necessary for a definitive diagnosis of neosporosis. By 
immunohistochemistry (Lindsay & Dubey, 1989b), specific antibodies are used to 
differentiate  N. caninum from other apicomplexan parasites in infected tissue 
sections. However, false positive N. caninum results have been recently observed 
in T. gondii-infected tissue sections (van Maanen et al., 2004). 
 
Isolation of the parasite 
To isolate the causative parasite, cell culture and inoculation of laboratory animals 
can also be used to recover N. caninum from infected tissues (Dubey et al., 
1988b). For example, BALB/c mice, IFN- gene knock out mice as well as gerbils 
have been used with success for in vivo parasite isolation (Cheah et al., 2004; 
Rodrigues et al., 2004; Vianna et al., 2005). The success of the method depends on 
the number of parasites present and the state of the tissue sample. 
 
Detection of parasite DNA 
N. caninum DNA can be detected by polymerase chain reaction (PCR). The 
various PCR protocols to detect N. caninum DNA that have been developed have 
played an important role in the diagnosis N. caninum infections. Different types of 
repetitive DNA have most frequently been used as targets (Baszler et al., 1999; 
Ellis, 1998; Gottstein et al., 1998; Holmdahl & Mattsson, 1996; Kaufmann et al., 
1996; Liddell, Jenkins & Dubey, 1999; Yamane et al., 1996). A competitive PCR 
assay has been developed to measure the level of N. caninum DNA in infected 
tissues (Liddell, Jenkins & Dubey, 1999). Presently, quantitative real-time PCR 
assays based on the use of SYBR-green detection systems or labelled probes have 
been successfully applied to detect and quantify the parasite DNA in infected 
tissue (Collantes-Fernandez et al., 2006; Collantes-Fernandez et al., 2002; Müller 
et al., 2002). This type of tool can be used to study the pathogenesis, tissue 
distribution and parasite load, etc., in a more sophisticated manner. Most of the 
real-time assays target the Nc5 region, a repeated sequence specific to the N. 
caninum genome (Kaufmann et al., 1996). 
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Immunity to N. caninum  
To design an effective vaccine, it is important to understand how the immune 
system responds to N. caninum. Immune responses to intracellular parasites 
include both humoral and cellular responses. Specific antibodies may play a role in 
limiting the spread of the extracellular stages. Nevertheless, protective immunity is 
achieved mainly through cell-mediated responses characterised by type 1 T-helper 
(Th1) cells and interleukin (IL)-2, IL-12 and IFN- production (Innes et al., 2000). 
Th2 responses, including IL-4 and IL-10 production, are generally considered to 
be unfavorable, and may lead to disease progression (Baszler, et al., 1999; Khan, 
et al., 1997). The protection is principally mediated by CD4
+, CD4
+ cytotoxic and 
CD8
+ cytotoxic cells (Staska et al., 2003; Tanaka et al., 2000a). IL-12 and IFN- 
produced by CD4
+ T cells in the spleens of mice infected with N. caninum are 
involved in disease resistance by inhibition of parasite proliferation and activation 
of macrophages (Baszler, et al., 1999; Innes et al., 1995; Khan, et al., 1997; 
Nishikawa et al., 2001c; Tanaka, et al., 2000a; Yamane et al., 2000). Suppression 
of IFN- and IL-12 production may allow greater parasite replication, resulting in 
more severe disease. Th1 and Th2 responses tend to down-regulate each other, and 
it has been shown that the balance of IFN-/IL-4 is important for the control of 
N. caninum infection (Long, Baszler & Mathison, 1998; Nishikawa et al., 2003). 
 
The aquired immunity is triggered by signals from the innate immunity during 
Neospora infection, and several components of the innate immunity have been 
shown to be activated. Proinflammatory cytokines such as IL-12, tumor necrosis 
factor (TNF)- and IFN- are released from macrophages, natural killer (NK) cells 
and dendritic cells. These cytokines play roles in killing of parasites and parasite 
infected cells and increase T-cell response to the parasite (Innes et al., 2000). For 
instance, activated macrophages induced by IFN- increase their nitric oxide   
production and killing activity against N. caninum (Tanaka et al., 2000b). In 
addtion, IFN- and TNF- are able to inhibit in vitro intracellular multiplication of 
N. caninum tachyzoites (Innes et al., 1995; Yamane et al., 2000). Moreover, NK 
cells, triggered by heat-killed N. caninum tachycoites, have been reported to 
increase their IFN- production and the killing of infected cells (Boysen et al., 
2006). 
 
Vaccination against neosporosis 
There are many different types of vaccines that could be considered. In general, 
live vaccines have the advantage of inducing long-lasting humoral and cell-
mediated immune responses. Because of endogenous antigen processing in the 
infected cells, cell-mediated responses are effectively generated. However, the 
disadvantages of live vaccines are the risk of causing disease and the possibility of 
causing persistent infections. In addition, there is a risk of contamination with 
unwanted microorganisms. 
 
An attenuated strain of N. caninum has been generated and found to induce 
protection in mice (Dreier et al., 1999; Lindsay et al., 1999c). However, further 
studies should be done in order to elucidate if it is safe for use in animals such as  17 
cattle and dogs, before it could be introduced as a vaccine against N. caninum 
infection. 
 
With killed vaccines there is no risk of causing persistent infection, and they are 
likely to be stable for storage and handling. Killed vaccines usually induce 
antibody production, although it might not be long-lasting. Also, they might not 
stimulate the cellular responses required for protection. 
 
There is an inactivated Neospora vaccine, Neoguard
TM, commercially available in 
parts of the world. It is composed of a lysate of tachyzoites formulated with a 
havlogen adjuvant. The vaccine has been shown to be safe to use (Choromanski, 
2002) and a reduction of the over all bovine abortion rate was demonstrated in a 
field study. However, the etiology of the abortions was not investigated (Romero 
et al., 2004). Another study showed that the proliferative response of peripheral 
blood mononuclear cells obtained from cattle immunised with a killed tachyzoite 
preparation associated with havlogen was significantly higher than of cells 
obtained from the negative control cattle, however, the production of IFN- was 
not different (Andrianarivo et al., 1999).  
 
At present, several research groups have designed different experimental subunit 
vaccines (Cannas et al., 2003a; Cannas et al., 2003b; Liddell et al., 2003; 
Nishikawa et al., 2001a). This work includes selection of appropriate parasite 
antigens in combination with a suitable adjuvant, in order to stimulate an effective 
protective immune response against N. caninum.  
 
N. caninum antigens  
A considerable amount of research has been done to define antigens of N. caninum 
using polyclonal antibodies, monoclonal antibodies and molecular biological 
methods (Dubey, 1999a). Neospora proteins and antigenic determinants are found 
in different locations of the parasite, and can be used for immunodiagnosis and 
vaccine development. 
 
Surface antigens 
Proteins located on the parasite surface are likely to be important for the survival 
of the parasites, and play an important role in the parasite-host interactions. Two 
major immunodominant surface antigens of N. caninum have been identified and 
the corresponding genes sequenced. Since their primary sequences are apparently 
homologous to the T. gondii surface antigen 1 (SAG1) (Burg et al., 1988) and 
SAG1-related sequences 2 (SRS2) (Manger, Hehl & Boothroyd, 1998), 
respectively, they have been designated NcSAG1 and NcSRS2 (Howe et al., 
1998). NcSAG1 was previously named Nc-p29 (Howe et al., 1998) or Nc-p36 
(Hemphill et al., 1997), and NcSRS2 was previously named Nc-p35 (Howe et al., 
1998) or Nc-p43 (Hemphill & Gottstein, 1996). NcSAG1 is found only on the 
tachyzoite surface (Hemphill et al., 1997), while NcSRS2 is expressed on both 
tachyzoites and bradyzoites (Fuchs et al., 1998; Hemphill & Gottstein, 1996). Both   18
antigens are involved in the process of adhesion to and invasion of host cells 
(Hemphill & Gottstein, 1996). These proteins in their native or recombinant form 
are currently used in Neospora-vaccine experiments. 
 
Microneme antigens  
Micronemes are secretory organelles found in the apical complex of N. caninum 
and related parasites. They are involved in the adhesion and invasion process, as 
the contents of these organelles are exocytosed at the onset of the parasite-host cell 
interaction (Carruthers & Sibley, 1997). In addition, microneme proteins have 
been shown to play a role in gliding motility of the tachyzoites (Sultan et al., 
1997). So far, more than 30 microneme proteins and genes of apicomplexan 
parasites have been identified (Tomley & Soldati, 2001), e.g. in Cryptosporidium, 
Eimeria,  Neospora,  Plasmodium,  Sarcocystis,  Theileria and Toxoplasma. A 
number of Neospora microneme proteins have been identified, including NcMIC1, 
NcMIC2, NcMIC3 and NcMIC4. Recombinant microneme proteins such as 
recombinant NcMIC1 and NcMIC3 have been used in vaccine experiments 
(Alaeddine et al., 2005; Cannas et al., 2003b). 
 
NcMIC1 is a 460 amino acid microneme protein of N. caninum expressed in the 
tachyzoite stage. Keller et al. (2002) showed that NcMIC1 is secreted and 
involved at the onset of the attachment between the parasite and the host cell, and 
also that NcMIC1 can bind to host cell-surface glycosaminoglycans.  
 
NcMIC2 is a member of the thrombospondin-related adhesive protein (TRAP) 
family found in apicomplexan parasites (Naitza et al., 1998). It is 61% identical to 
T. gondii MIC2 as regards its amino acid sequence, and it is localised to the 
micronemes (Hemphill et al., 1999). 
 
NcMIC3 is a 38 kDa antigenic protein expressed in both tachyzoites and 
bradyzoites, and could be involved in adhesion and invasion of the host cell 
(Sonda et al., 2000). NcMIC3 is secreted and bound to the tachyzoite surface, and 
could be detected on the surface membrane within 2–3 h after host-cell invasion 
(Naguleswaran et al., 2001). It has been shown that NcMIC3 interacts with host 
cell-surface proteoglycan (Naguleswaran et al., 2002). 
 
NcMIC4 is a 55 kDa lectin-like microneme protein exhibiting lactose-binding 
properties. It has been shown that NcMIC4 is also secreted by N. caninum 
tachyzoites at the onset of adhesion to the host cell. It can bind to the host cell-
surface glycosaminoglycans (Keller et al., 2004).   
 
Dense granule antigens 
The dense granules are secretory organelles found in all coccidian parasites. The 
parasites secrete dense granule contents into the lumen of the parasitophorous 
vacuole after host-cell invasion. To date, five dense granule antigens of 
N. caninum have been identified, including NcGRA1 (Atkinson et al., 2001), 
NcGRA2 (Ellis et al., 2000), NcGRA6 or NCDG2 (Liddell et al., 1998), NcGRA7  19 
or NCDG1 or Nc-p33 (Hemphill et al., 1998; Lally et al., 1997), and the 
nucleoside triphosphate hydrolase (NcNTP or NTPase) (Asai et al., 1998). 
 
Immunostimulating complexes (iscoms) 
One of the adjuvants that has been used in experimental vaccines against 
N. caninum with promising results (Lundén et al., 2002) is the immunostimulating 
complexes (iscoms), invented by Morein and coworkers in 1984 (Morein et al., 
1984). Iscoms are spherical 40 nm cage-like structures, composed of the saponin 
adjuvant Quil A from the bark of the tree Quillaja saponaria, cholesterol, 
phospholipids, and multiple copies of one or several proteins or antigens. Similar 
particles without any antigen can also be produced, and are called iscom matrix. 
They can be used for coupling to different antigen molecules. 
 
Iscoms have been shown to increase the immunogenicity of the incorporated 
antigens, and to induce humoral and cell-mediated immunity in animals (Morein et 
al., 1995; Sjolander, Cox & Barr, 1998) and humans (Sjolander et al., 2001). The 
adjuvant and carrier properties of iscoms include: 
1.  Physical presentation of several copies of proteins or antigens 
incorporated into the iscoms (Morein et al., 1995). 
2.  Enhancement of uptake and internalisation of antigens by antigen 
presenting cells (Villacres et al., 1998). 
3.  Stimulation of proinflammatory cytokine production by antigen 
presenting cells. Both iscoms and the iscom matrix stimulate IL-1, IL-6 
and IL-12 production (Behboudi, Morein & Villacres-Eriksson, 1996; 
Behboudi, Morein & Villacres-Eriksson, 1997; Villacres-Eriksson et al., 
1997), and therefore T-helper cells and cytotoxic T cells are activated, 
and antibody responses are generated. 
4.  Increased expression of major histocompatibility complex class II   
(Bergström-Mollaoglu et al., 1992; Watson et al., 1992). 
 
In addition to vaccine development, the iscom technology can be used to prepare 
antigens for immunoassays. Serological assays using iscom antigen preparations 
have been successfully employed for the diagnosis of T. gondii and N. caninum 
using ELISA (Björkman & Lundén, 1998). 
 
Iscoms have been constructed with a wide range of viral, bacterial or parasite 
antigens. Several methods have been developed to construct iscoms containing 
different proteins and peptides, including recombinant antigens. The 
ultracentrifugation and dialysis methods could be used for hydrophobic or 
amphipathic antigens, which are incorporated into iscoms through hydrophobic 
interaction (Morein & Lövgren Bengtsson, 1999). 
 
Electrostatic interaction can also be utilised for preparation of iscoms, since 
matrix particles generally are negatively charged and positively charged molecules 
such as nucleoprotein can attach to them (Morein, Hu & Abusugra, 2004). 
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For incorporation of hydrophilic antigens, several techniques could be applied, 
for instance: low pH treatment of the antigen to expose hidden hydrophobic parts, 
or by conjugating lipids to the antigen. Chemical covalent binding could be used 
for coupling hydrophilic antigens and synthetic oligopeptides to a pre-formed 
iscom matrix containing a phospholipid suitable for conjugation, e.g. 
phosphatidylethanolamine (Morein & Lövgren Bengtsson, 1999). 
 
Different affinity interactions have recently been tried to couple recombinant 
proteins to iscom matrix. For example, recombinant proteins with a hexahistidyl 
peptide (His6) tag can, via divalent anions, bind to iscom matrix containing a 
chelating lipid (Andersson et al., 2001).   21 
Aims  
The aims of the present study were: 
 
•   To evaluate methods for incorporation of recombinant proteins into iscoms 
using the affinity between biotin and streptavidin (Paper I).  
 
•   To investigate if the recombinant N. caninum antigen NcSRS2, expressed in 
Escherichia coli with fusion partners selected for affinity purification and 
association to iscoms, could induce antibodies that recognised the native 
parasite protein (I, II). 
 
•  To investigate whether the NcSRS2 iscoms could generate protective immunity 
against cerebral neosporosis in mice (II). 
 
•  To compare different NcSRS2-iscoms prepared by the methods described in 
Paper I as regards immunogenicity, including both humoral and cellular 
responses, and protective capacity against challenge infection (III). 
 
•  To explore the possibility of using real-time PCR for the detection and 
quantification of parasitaemia in mice, and to use this parameter for further 
evaluation of the protective effect of the NcSRS2-iscoms (IV).    22
Comments on materials and methods 
The materials and methods are described in detail in Papers I–IV. 
 
Recombinant proteins and iscoms 
The well-known bio-specific interaction between biotin and streptavidin, as well as 
the chemical affinity between histidine and metal ions, were utilised for binding 
recombinant antigens to iscom matrix. Two different concepts for binding via 
biotin and streptavidin were followed: (i) indirect binding of a biotinylated antigen 
via recombinant streptavidin with a His6-tag that was bound to iscom matrix 
loaded with Ni
2+ ions (Fig. 2A), and (ii) direct binding of streptavidin fusion 
proteins to biotinylated matrix (Fig 2B). In addition, since the streptavidin fusion 
proteins contained a His6-tag, one of them was also bound to Ni
2+-loaded matrix 
for comparative studies (Fig. 2C). 
 
The model antigens selected for evaluation of these concepts were SRS2´, a 232 
amino acid segment derived from the central region of the N. caninum major 
surface antigen NcSRS2, and the malaria peptide M5, a 53 amino acid petide 
derived from the central region of the Plasmodium falciparum blood-stage antigen 
Pfl55/RESA. The recombinant antigens and their fusion partners were expressed in 
E. coli strain BL21 (DE3).  
 
Three kinds of iscom matrix were used: regular, metal-chelating and biotinylated 
iscom matrix (denoted matrix, IDA-matrix and Bio-matrix, respectively). All three 
types of matrix were prepared from cholesterol, phosphatidylcholine and Quil A. 
The IDA-matrix also contained the chelating lipid IDA-Trig-DSGE. For 
activation, the IDA-matrix was incubated with NiCl2 and thereafter dialysed to 
remove unbound Ni
2+ ions. The resulting preparation was denoted Ni
2+-matrix. To 
prepare Bio-matrix, matrix containing phosphatidylethanolamine was biotinylated 
with N-hydroxysuccinimide-biotin. 
 
Recombinant fusion proteins 
For the first concept (indirect binding), two fusion proteins consisting of a tag 
(Bio) for in vivo biotinylation by E. coli, a His6-tag, an albumin binding protein 
(ABP) and SRS2´ or M5 were designed, and denoted Bio-His6-ABP-NcSRS2’ and 
Bio-His6-ABP-M5. The ABP and His6-tag were included for affinity purification. 
To investigate whether increased biotinylation would increase binding to the 
iscoms, Bio-His6-ABP-SRS2’ was biotinylated in vitro, and the double 
biotinylated fusion protein was denoted Bio-Bio-His6-ABP-SRS2’. For linking the 
biotinylated antigens to Ni
2+-matrix, a His6-tagged streptavidin fusion protein 
(His6-SA) was produced.  
 
For the second concept (direct binding), recombinant NcSRS2 and M5 were 
expressed as His6-tagged streptavidin fusion proteins (denoted His6-SA-SRS2’ and  23 
His6-SA-M5, respectively). The His6-tag was originally included for affinity 
purification, but was also used for binding to Ni
2+-matrix, to enable comparison 
between iscoms prepared from Bio-matrix and Ni
2+-matrix (III). 
 
After sonication of E. coli cells, the His6-SA, His6-SA-SRS2’ and His6-SA-M5 
fusion proteins were purified by His6-tag-mediated immobilized metalloaffinity 
chromatography (IMAC) on Co
2+-charged affinity resin columns under denaturing 
conditions. The Bio-His6-ABP-M5’ and Bio-His6-ABP-NcSRS2’ fusion proteins 
were purified by ABP-mediated affinity chromatography on HSA (human serum 
albumin)-Sepharose. The presence and size of the fusion proteins were determined 
by SDS-PAGE and Western blotting, using M5-specific polyclonal antibodies and 
a monoclonal antibody to NcSRS2 (I).  
 
 
 
Fig. 2. Schematic presentation of the two concepts (A & B) used for association of 
recombinant antigens by biotin-streptavidin interaction. (A): indirect binding of a 
biotinylated protein via His6-SA to Ni
2+-matrix; (B): direct binding of a streptavidin fusion 
protein to biotinylated matrix; (C): binding of a His6-tagged protein to Ni
2+-matrix. 
 
Iscom preparation 
According to the first concept, pre-formed Ni
2+-matrix was incubated with the 
His6-SA protein. Thereafter, the Bio-His6-ABP-M5’, Bio-His6-ABP-NcSRS2’ or 
Bio-Bio-His6-ABP-SRS2’ fusion proteins were added, and the mixture incubated 
again before dialysis overnight.  
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For the second concept, the His6-SA-SRS2’ or His6-SA-M5 fusion proteins were 
directly mixed with Bio-matrix and incubated, in order to establish the direct 
association through the biotin-streptavidin interaction, and dialysed overnight. A 
similar procedure was used to bind His6-SA-SRS2’ to Ni
2+-matrix. 
 
To analyse the association of the different proteins to the matrix and to each 
other, the iscom preparations were centrifuged through a sucrose gradient and 
fractionated. The fractions were analysed for the presence of Quil A and proteins 
by measuring the absorbance at 214 and 280 nm, respectively. The protein content 
was also determined by Bradford analysis. To trace the different fusion proteins, 
aliquots of each fraction were coated into separate wells of ELISA plates, followed 
by incubation with specific antibodies direct against NcSRS2, M5 or streptavidin.  
 
Table 1. Iscom preparations used for immunisation 
                                      
 
Full name used in Paper I  Abbreviated name used in Papers II–IV*   
   II  III  IV   
                                      
 
Ni
2+-matrix + His6-SA + Bio-  NcSRS2 iscom  BioSRS2´-iscom(Ni)   
 His6-ABP-SRS2’ 
 
Ni
2+-matrix + His6-SA + Bio-    dBioSRS2´-iscom(Ni) 
 bio-His6-ABP-SRS2’ 
  
Biotin-matrix + His6-SA-SRS’   SA-SRS2´-iscom(Bio)  as  in  III 
 
Ni
2+-matrix + His6-SA-SRS2’   SA-SRS2´-iscom(Ni)  as  in  III 
 
Ni
2+-matrix + His6-SA + Bio-  M5 iscom  M5-iscom(Ni)     
His6-ABP-M5          
                                      
 
* The abbreviations from Paper III are used in the text of the thesis. 
 
Immunisations and challenge infections  
Inbred BALB/c mice were used, since they are susceptible to infection with 
N. caninum and develop clinical neosporosis (Lindsay et al., 1995a; Long, Baszler 
& Mathison, 1998). All immunisations and inoculations with parasites were done 
subcutaneously at the base of the tail. The different SRS2´-iscom preparations 
used are listed in Table 1, and are referred to with the abbreviated names used in 
Paper III. 
 
In Paper I, two iscom preparations, prepared according to the first concept with 
the  in  vivo biotinylated fusion proteins Bio-His6-ABP-M5 and Bio-His6-ABP-
SRS2’ (Table 1) were selected to investigate whether the recombinant antigens 
could induce specific antibodies recognizing the target immunogens M5 and 
NcSRS2. In addition, a third group of mice was immunised with a mixture of 
regular matrix, His6-SA and Bio-His6-ABP-SRS2’, to evaluate the immunogenicity 
of Bio-His6-ABP-SRS2’ when not specifically bound the matrix. The antibody 
responses were analysed by ELISA with ZZM5, an unrelated M5 fusion protein, or 
iscoms containing NcSRS2 of parasite origin as coating antigens.  25 
In  Paper II, the protective effect of the SRS2´-iscom preparation used in 
Paper I (BioSRS2’-iscom(Ni)) was evaluated by challenge infection. Control 
mice were immunised with the corresponding M5-iscom preparation (BioM5-
iscom(Ni)). The antibody responses against native NcSRS2 were analysed by 
ELISA and Western blotting. After inoculation with 10
7 live N. caninum 
tachyzoites, the mice were weighed daily and clinical signs of neosporosis were 
recorded. After 31 days the mice were killed, and their brains analysed by 
competitive PCR for quantification of parasite DNA. 
 
Paper III further evaluated and compared the immunogenicity of the different 
NcSRS2 iscom formulations prepared according to the two concepts of iscom 
association via biotin-streptavidin binding. In a first experiment, groups of mice 
were immunised with Bio-His6-ABP-SRS2’, Bio-Bio-His6-ABP-SRS2’ or His-SA-
SRS2´ alone or bound to streptavidin-coated or biotinylated matrix as described in 
Paper I. After analysis of the antibody and cellular immune responses, two of the 
iscom formulations (BioSRS2´-iscom(Ni) and SA-SRS2-iscom (Bio)) were 
selected for a second experiment, along with a new preparation of His6-SA-SRS2´ 
bound to Ni
2+-matrix (SA-SRS2´-iscom(Ni)). After two immunisations, as well as 
at the end of the challenge experiment, sera from the individual mice were 
analysed for antibodies to native NcSRS2 (experiments 1 and 2) and recombinant 
SRS2´ (experiment 2), including IgG subclass analysis. From some of the mice, 
the spleens were removed after the booster injection, and splenocyte suspensions 
were prepared for analysis of antigen specific proliferation and cytokine 
production. In the second experiment, the remaining mice were inoculated with 
live tachyzoites and monitored as in Paper II for 23 days. At the end of the 
experiment their brains were collected and analysed by quantitative real-time PCR. 
 
The aims of the work described in Paper IV were to evaluate whether the real-
time PCR assay that was set up and described in Paper III was sensitive enough to 
detect parasitaemia after experimental infection, and to investigate whether the 
immunity induced by the NcSRS2 iscoms could reduce the level of parasitaemia. 
The relationship between the level of parasitaemia during the acute stage and the 
amount of parasites in the brain in the chronic stage was also investigated. In an 
initial experiment, mice were inoculated with different numbers of tachyzoites, 
blood samples were colleted every second day for 12 days, and thereafter with 
longer intervals until the end of the experiment at 25 days post inoculation. For the 
immunisation experiment the two iscom preparations SA-SRS2’-iscom(Bio) and 
SA-SRS2´-iscom(Ni) were selected, and blood was collected daily for nine days 
after challenge infection. 
 
Parasites 
The NC-1 isolate of N. caninum (Dubey et al., 1988b) was used to prepare antigen 
for ELISA (I–IV), immunoblotting (II, III) and lymphocyte stimulation test (III), 
as well as for challenge infection (II–IV). The parasites were propagated in vitro 
in Vero cells. For challenge infection, parasites with a low passage number were 
used, since it has been shown that N. caninum can lose its virulence after many   26
passages in cell culture (Bartley et al; 2006). Furthermore, care was taken to 
harvest the parasites at an optimal time point, to minimise loss of infectivity after 
the rupture of the host cells (Hemphill, 1999). 
 
Antibody and IgG subclass analysis 
Blood was collected from the tail vein after each immunisation (I–III) and after 
challenge infection (III), and the antibody response was analysed by ELISA. The 
antigens used to measure the response against recombinant M5 and NcSRS2 were 
the recombinant protein ZZM5 (I) and His6-SA-SRS2 (III), respectively. To detect 
antibodies that reacted with native NcSRS2, iscoms containing surface antigens 
extracted from N. caninum tachyzoites were used as coating antigen (I–IV). The 
sera were titrated in serial three-fold dilutions from 1:30, and the results were 
expressed as reciprocals of the dilution giving an absorbance of 1.0. Horse-radish 
peroxidase (HRP)-conjugated rabbit anti-mouse immunoglobulin (Ig) was used for 
total Ig analysis, and HRP-conjugated caprine antibodies to murine IgG1 and 
IgG2a were used for analysis of these two subclasses. Since IgG2a production is 
stimulated by Th1 cytokines, and Th2 cytokines promote IgG1 production, these 
subclasses are often used as a measure of the Th1/Th2 balance. 
 
The antibody response of the immunised mice was also analysed by 
immunoblotting (II).  N. caninum-iscoms and BioSRS2´-iscoms(Ni) were 
separated by SDS-PAGE under non-reducing conditions, and transferred to 
nitrocellulose membranes. The reactivity of the sera from the immunised mice was 
compared to that of sera from N. caninum-infected mice, a monoclonal antibody 
against NcSRS2, and polyclonal sera against streptavidin. HRP-conjugated rabbit 
anti-mouse Ig was used as secondary antibody.  
 
Analysis of cellular responses  
Cellular immune responses after immunisation were evaluated by a lymphocyte 
stimulation test (III). The test was used to measure antigen-specific proliferative 
responses and cytokine production. Since resistance to neosporosis is associated 
with Th1 cytokines such as IFN-, and susceptibility with Th2-cytokines such as 
IL-4, these two cytokines are often measured to evaluate the cellular immune 
responses against N. caninum. 
 
Spleen cells were isolated from mice after booster immunisation. The cells were 
plated into 96-well culture plates, and stimulated with N. caninum lysate or the 
mitogen Concanavalin A (Con A). The cells were incubated for 96 h, and tritium-
labelled thymidine was added before another 18 h incubation. Thymidine 
incorporation was measured as count per minute (cpm) using a -scintillation 
counter. The proliferative responses were expressed as net cpm according to the 
formula: 
 
Net cpm = mean cpm of stimulated cultures – mean cpm of control cultures.  27 
The cytokine-producing ability was studied in cultures of splenocytes incubated 
with N. caninum lysate as specific stimulator or Con A as positive control. The 
culture supernatants were analysed by commercial ELISA kits, each containing 
two monoclonal antibodies (capture and detection antibody) to murine IL-4 or 
IFN-, and recombinant IL-4 or IFN- for the standard curves used for 
quantification. 
 
Detection and quantitative analysis of N. caninum DNA 
Two different PCR assays, including semiquantitative competitive PCR (II) and 
real-time PCR (III, IV), were used to demonstrate and quantify N. caninum DNA 
after challenge infection. The competitive PCR is based on amplification of the 
Nc5 repeated sequences, with the primers Np6+ and Np21+ (Liddell, Jenkins & 
Dubey, 1999). This PCR assay is performed with a conventional thermocycler. 
The basis of the assay is to transform a qualitative assay to a quantitative assay by 
adding a known amount of a mimic competitor molecule. This competitor is 
specifically amplified by the same primers as the target DNA, although its size has 
to be different. Both target sequence and competitor are amplified in the same 
tube; and by setting up the reaction with serial dilutions of the competitor, the 
quantity of the target amplicon can be estimated after visualisation of the bands on 
agarose gels. The concentration of the competitor that gives equally strong bands 
for the target and mimic is assumed to correspond to the concentration of the 
target. The competitor molecule also functions as a control for false-negative 
reactions. Although this assay is considered to be a sensitive method, with a 
detection level of 0.09 pg N. caninum tachyzoite DNA (Liddell, Jenkins & Dubey, 
1999), it has several disadvantages compared to quantitative real-time PCR. For 
example, the serial-diluted tube format and post-PCR gel electrophoresis are 
laborious and time-consuming.  
 
Real-time PCR is a high-throughput method that does not involve any post-
amplification manipulations, which decreases the risk of cross-contamination and 
saves time. The assay uses fluorescent labels for continuous monitoring and 
detection of the amplicon (PCR product) formation. Depending on the amount of 
starting target DNA, it will take a certain number of cycles before the fluorescent 
signal crosses a threshold level. This cycle number is named the cycle threshold 
(Ct) value, which is inversely correlated to the initial amount of the template. A 
standard curve with Ct values of known standards can be generated, and the 
starting amounts of the template in unknown samples are calculated from the curve 
according to their Ct values. 
 
The real-time PCR assay used in the present work was based on detection of the 
Nc5 sequence, using the primer pairs Np6+ and Np21+ and SYBR Green as 
detection system. SYBR Green binds to double-stranded DNA, and emits strong 
fluorescence measured at a particular point during each amplification cycle.  
 
The main limitation of using SYBR Green is non-specific binding to any double-
stranded DNA. Therefore, SYBR Green would bind to primer-dimers, and any   28
products that have been amplified un-specifically, as well as to the target 
amplicon. To improve the specificity of the assay, highly specific primers with low 
risk of primer-dimer formation, and the optimisation of the PCR protocol, should 
be considered. In the present study, samples from Paper  III  were initially 
analysed with the real-time PCR assay described by Collantes-Fernandez et al. 
(2002). However, the product melting curve analysis suggested that some degree 
of unspecific amplification occurred. This observation was verified after agarose-
gel electrophoresis. The performance of the real-time PCR was significantly 
improved after switching primers to those used in Paper II and optimisation of the 
cycling conditions. Consequently, all samples were analysed with this new PCR 
system. Nevertheless, end-point agarose gel electrophoresis with ethidium bromide 
staining was performed on samples that had Ct-values close to those of the 
negative control. In the present studies, a product-melting curve analysis was 
performed to reveal the presence of primer-dimer formation or unspecific 
amplification. It was found that some unspecific amplification occurred, and 
sometimes the melting point of the unspecific product was close to that of the 
target. Consequently, agarose gel electrophoresis with ethidium bromide staining 
was also performed, before final judgement of samples that had Ct values close to 
those of the negative control. 
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Results and discussion 
Binding of recombinant proteins to iscom matrix (Papers I, III) 
The association of the different proteins to iscom matrix was evaluated by 
analytical ultracentrifugation. Typically, iscoms are located in the mid fractions of 
the gradients, while most of the unassociated proteins are found in the upper 
fractions. When iscoms were prepared according to the first concept (Fig. 2A), a 
large proportion of the fusion proteins were detected in the Quil A-rich mid 
fractions (Fig. 3A). In contrast, when the proteins were analysed alone they were 
found in the upper fractions of the gradient. This indicates that the two in vivo 
biotinylated fusion proteins (Bio-His6-ABP-M5 and Bio-His6-ABP-SRS2’) were 
successfully bound to streptavidin-coated iscom matrix. 
 
Interestingly, control experiments showed that regular matrix to some extent 
associated with His6-SA and the biotinylated immunogens (Bio-His6-ABP-M5 or 
Bio-His6-ABP-SRS2’). However, the vast majority of the proteins remained 
unassociated, indicating that this unspecific adherence was not as strong as the 
binding to Ni
2+-matrix via His6-SA. The immunogenicity of Bio-His6-ABP-SRS2’ 
mixed with regular matrix was investigated (I), and is discussed in a later section. 
 
Since the biotinylated immunogens (Bio-His6-ABP-SRS2’ and Bio-His6-ABP-
M5) contained a His6-tag, it could be argued that they might bind directly to the 
Ni
2+-matrix instead of indirectly via the His6-SA. To minimize this unintended 
binding, the His6-SA protein was pre-incubated with Ni
2+-matrix before the 
biotinylated immunogens were added. Moreover, since the biotin-streptavidin 
interaction is at least 100 times stronger than the His6-Ni
2+ binding (Wilchek & 
Bayer, 1990; INDIA
TM HRP-method, Pierce), this former interaction is likely to 
dominate over the latter. 
 
To explore the effect of increased biotinylation, Bio-His6-ABP-SRS2’ was 
biotinylated in vitro, and this  double-biotinylated protein was used for preparation 
of iscoms according to the first concept. Comparison of iscoms prepared with the 
in vivo biotinylated protein and with the double-biotinylated protein indicated that 
the increased bitinylation seemed to give a more efficient binding (Fig 3A and B). 
However, the interpretation of the analytical centrifugations was complicated by 
the fact that when the double-biotinylated protein was analysed without matrix a 
substantial proportion of it was located in the mid fractions of the gradient, 
probably due to aggregation of the protein (Fig. 3C). All three preparations shown 
in Fig. 3 were used in an immunisation experiment (III), presented in a later 
section.  
 
Evaluation of iscoms prepared according to the second concept revealed that 
both His6-SA-M5 and His6-SA-SRS2’ were found in the Quil A-rich middle 
fractions, indicating successful association to the biotinylated matrix. In control 
experiments, His6-SA-M5 was found in the upper fractions when analysed alone or 
with regular matrix, while His6-SA-SRS2’ was localized in the mid fractions,  30
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Fig. 3. Analysis of Quil A and protein content in fractions collected from sucrose-density-
gradient centrifugation of iscom preparations. (A): BioSRS2’-iscom(Ni); (B): dBioSRS2’-
iscom(Ni); (C): Bio-Bio-His6-ABP-SRS2’.  31 
whether analysed alone or together with regular matrix. Thus, it seems likely that 
both proteins were successfully bound to the Bio-matrix, although it could not be 
shown as clearly for the SRS2’ protein as for the M5 protein (I). 
 
The iscoms prepared by binding His6-SA-SRS2’ to Ni
2+-matrix (III) were also 
analysed by centrifugation through a sucrose gradient, and the protein was only 
detected in the Quil A-rich fractions. 
 
Thus, both concepts for binding (via biotin and streptavidin) were demonstrated 
to give successful iscom association of immunogens. However, the expression 
levels of the in vivo biotinylated protein used according in the first concept seemed 
to be unimpressive (2–4 mg/l of cell culture), whereas the streptavidin fusion 
proteins used in the second concept were expressed at higher level (62–84 mg/l of 
cell culture). Furthermore, the second concept is obviously simpler; involving only 
one fusion protein binding to the biotinylated matrix. Also, the biotin-streptavidin 
interaction is much stronger than the histidine-Ni
2+ binding. Thus, a direct 
association through biotin-SA interaction is probably preferable to the indirect 
approach. 
 
Analysis of B-cell epitopes of the recombinant NcSRS2 (I, II, III) 
The amino acid sequence of NcSRS2 shows homology to the SAG and SRS 
antigens of T. gondii (Howe et al., 1998). Although antigenically distinct from 
these proteins (Fuchs et al., 1998), NcSRS2 can be assumed to have a similar 
secondary and tertiary structure (Howe et al., 1998). For TgSAG1, it has been 
shown that many B-cell epitopes are conformational and dependent on the proper 
formation of disulphide bridges (Velge-Roussel et al., 1994). Production of 
correctly folded TgSAG1 in E. coli has met considerable problems, while 
expression in eukaryotic systems has generally been successful (Biemans et al., 
1998; Kim et al., 1994). Since NcSRS2 contains 12 cystein residues that are 
conserved in the T. gondii SAG and SRS antigens (Howe et al., 1998), similar 
problems with expression in prokaryotic cells can be expected. 
 
Therefore, to investigate if the recombinant SRS2´ could induce antibodies that 
recognised native NcSRS2, mice were immunised with one of the iscom 
preparations (BioSRS2´-iscom(Ni)). After two immunisations, N. caninum-
specific antibodies were detected with an average titre of 1:10784, which was only 
about two dilution steps lower than for pooled sera collected from mice inoculated 
with live N. caninum tachyzoites (I). This strong reactivity to the native NcSRS2 
antigens, together with the recognition of recombinant SRS2’ by the monoclonal 
antibody mab 5.2.15 raised to native N. caninum antigens, as well as by sera from 
N. caninum infected mice in immunoblotting (I, II), suggested that the 
recombinant SRS2´ protein was properly configured. 
 
Similarily, mice were immunised with one of the M5-iscom preparations (M5-
iscom(Ni)), in order to evaluate their capability to induce antibodies that   32
recognised the target antigens M5. These mice produced antibodies reacting with 
an unrelated recombinant M5 fusion protein with a mean titre of 1:452 (I). 
 
To further investigate the antigenic structure of the recombinant SRS2´, the four 
different kinds of SRS2´ iscom preparations were analysed with immunoblotting 
using the two monoclonal antibodies mab 5.2.15 and NcMab-10 to NcSRS2 
(Björkman & Hemphill, 1998; Schares et al. 1999; A. Hemphill, personal 
communication), and serum from infected mice. The two monoclonal antibodies 
were first tested in a competive ELISA, which showed that they recognise 
different epitopes (data not shown). The recombinant SRS2´, in all four iscom 
formulations, was recognised by the polyclonal serum and mab 5.2.15, but not by 
NcMab-10, while native NcSRS2 antigen was stained by both monoclonal 
antibodies (III). This indicated that the recombinant SRS2´ possess some B-cell 
epitopes present in the native NcSRS2, but lack at least one of them. It is possible 
that the epitope recognised by NcMab-10 is located outside the segment of 
NcSRS2 that constitutes SRS2´. 
 
 
Fig. 4. Antibody titres against native N. caninum antigens for mice measured both after 
immunisation with SRS2´-iscoms and after challenge infection with live parasites. The 
subclass-specific conjugate was used at two different dilutions, 1: 10 000 and 1:2 000.  
 
Futhermore, the IgG sublass analysis of sera from immunised and infected mice 
revealed possible differences in the antigenicity of the recombinant antigens and 
the native NcSRS2. The subclass titres against the native antigens, IgG1 as well as 
IgG2a, induced by immunisation were low in relation to the total Ig titres. In 
contrast, the subclass titres against the recombinant protein were much closer to 
the total Ig titres, a pattern that was also seen in the N. caninum-specific antibody 
response after infection (III). Theoretically, the discrepancy between the total Ig 
and subclass titres could be due to the dominance of isotypes other than IgG, or 
subclasses other than IgG1 and IgG2a. Alternatively, and more likely, it could be 
caused by differences in the ELISAs used for detection of total Ig and the 
subclasses.  33 
To test this hypothesis, the concentration of the subclass-specific secondary 
antibodies was increased, to test some sera collected from immunised mice before 
and after challenge infection. This resulted in increased subclass titres for sera 
collected before infection, but did not affect the titres of sera taken after challenge 
infection (Fig. 4). This can be interpreted as a low specificity and/or affinity of the 
antibodies induced by the recombinant proteins, as compared to those induced by 
infection. Thus, it is likely that, although the recombinant antigens obviously 
contain some of the B-cell epitopes of the native antigen, others are missing or not 
properly exposed. 
 
Nevertheless, the finding that the SRS2´-iscoms induced antibodies that reacted 
with the native antigen was considered to be promising, since previous studies 
using other recombinant NcSRS2 proteins indicate that protective immunity is 
associated with production of antibodies that react with native NcSRS2. Cannas et 
al. (2003a) reported that mice immunised with a recombinant SRS2 protein 
produced antibodies reacting to the recombinant protein but not to native parasite 
antigen, whereas immunisation with NcSRS2-DNA followed by a single injection 
of recombinant NcSRS2 induced antibodies recognising the native antigen. After 
challenge infection, a significant reduction in the number of mice with detectable 
parasite DNA in their brains was observed in the group given the DNA vaccine, 
but not in mice immunised with recombinant protein without priming with DNA-
vaccination. Therefore, it was worthwhile continuing to evaluate the 
immunogenicity and protective capacity of the SRS2´-iscoms. 
 
Comparison of immune responses induced by the different 
NcSRS2 iscom formulations (I, II, III) 
In Paper III, the immunogenicity of three different SRS2´-iscom preparations was 
compared with that of the corresponding recombinant SRS2’ without any adjuvant. 
The preparations used were: 
BioSRS2´-iscom(Ni) and Bio-His6-ABP-SRS2’ 
dBioSRS2´-iscom(Ni) and Bio-Bio-His6-ABP-SRS2’ 
SA-SRS2´-iscom(Bio) and His6-SA-SRS2’. 
 
It was found that two of the iscom preparations (BioSRS2´-iscom(Ni) and SA-
SRS2´-iscom(Bio)) induced high levels of N. caninum-specific antibodies, while 
only very low titres were detected in mice given the corresponding recombinant 
proteins Bio-His6-ABP-SRS2’ or His6-SA-SRS2’ without adjuvant. Analysis of 
antigen-specific cellular responses revealed that only cells obtained from mice 
immunised with BioSRS2´-iscom(Ni) or SA-SRS2´-iscom(Bio) produced 
significantly higher level of IFN- and IL-4 than did cells from unimmunised mice 
(P<0.05 and P<0.01 for IFN-;  P<0.05 and P<0.05 for IL-4). These results 
clearly demonstrate the adjuvant effect of the iscom, and the capacity of these two 
SRS2´-iscoms to induce N. caninum-specific cellular response.  
 
In contrast, the double biotinylated SRS2´ without adjuvant induced high 
antibody titres that were comparable to those generated by the corresponding   34
iscom preparation. Furthermore, no N. caninum-specific IFN- or IL-4 production 
was detected in cultures from mice immunised with this protein, either alone or in 
association with iscoms. These results suggest that the high antibody titres 
observed in mice injected with double-biotinylated SRS2´-iscoms might not be 
attributable to the adjuvant effect of the iscom. Since there was no proliferative 
response of cells obtained from mice injected with double-biotinylated SRS2´ 
iscoms, it is possible that the protein was not properly associated with the matrix, 
and that aggregation of the protein was the reason for its localisation in the Quil A-
rich fractions of the gradient. This is also a likely explanation for its capacity to 
stimulate an antibody response even without any adjuvant.  
 
In  Paper I, mice immunised with SRS2´-iscoms (BioSRS2´-iscom(Ni)) 
produced specific antibodies reacting to N. caninum antigens with a mean titre 
1:10784. However, the same level of N. caninum-specific antibodies (with a mean 
titre of 1:14,355) were also observed in mice immunised with regular iscom matrix 
mixed with His6-SA and Bio-His6-ABP-SRS2’. As mentioned above, analysis of 
sucrose-gradient ultracentrifugation of the former iscom preparation showed 
successful iscom association, whereas the latter mixture showed minimal iscom 
association of both fusion proteins. The reason for this unspecific binding is not 
clear. Nevertheless, the addition of regular matrix to the protein was sufficient for 
inducing an antibody response to N. caninum SRS2 antigen. To further examine 
the immunogenicity of this preparation, it would be of interest to investigate 
whether cellular responses could be generated.  
 
In Paper II, immunoblotting analysis confirmed that the antibody responses to 
N. caninum antigens measured by ELISA were directed against NcSRS2. 
 
In a further experiment (III), the immunogenicity and protective effect of the 
two iscom preparations BioSRS2´-iscom(Ni) and SA-SRS2´-iscom(Bio), was 
compared to another preparation containing SA-SRS2´-iscom(Ni), which was 
included to test the influence of biotinylated matrix (Bio-matrix) and Ni
2+-loaded 
matrix on the immunising effect. Control groups were injected with M5-iscom(Ni) 
or with IDA matrix. 
 
The results of antibody and subclass analyses after the second immunisation 
showed that high levels of N. caninum-specific antibodies were detected in sera 
from all mice in all three SRS2´-iscom immunised groups, whithout any 
significant differences between the groups. Only very low antibody titres were 
detected in sera from mice immunised with the M5-iscoms, and no antibodies were 
detected in sera from mice given IDA-matrix. Also, N. caninum-specific IgG 
subclasses (IgG1 and IgG2a), of which IgG1 dominated, were detected in all three 
SRS2´-iscom immunised groups, although at relatively low levels compared with 
the titres for total Ig to N. caninum.  
 
Significant antigen-specific proliferative responses were detected in cell cultures 
obtained from mice immunised with all three different SRS2´ iscoms [BioSRS2´-
iscom(Ni) (Group 1), SA-SRS2´-iscom(Bio) (Group 2), and SA-SRS2´-iscom(Ni) 
(Group 3)], but not in cell cultures obtained from mice immunised with either the  35 
M5-iscoms or IDA-matrix. In addition, high levels of both IFN- and IL-4 were 
detected in antigen-stimulated cultures from all three groups given different SRS2´ 
iscom preparations. The cytokine analysis revealed that cells from mice 
immunised with SA-SRS2´-iscom(Bio) (Group 2) produce significantly higher 
IFN- than did the other immunised mice (Groups 1 and 3), and the IL-4 levels in 
Group 2 were significantly higher than in cultures from mice in Group 3. 
 
In conclusion, the three SRS2´ iscom preparations, BioSRS2´-iscom(Ni), SA-
SRS2´-iscom(Bio) and SA-SRS2´-iscom(Ni), were all capable of inducing 
N. caninum-specific humoral and cellular responses. However, the highest levels 
of IFN- production were detected in cell cultures from mice given Bio-
matrix+His6-SA-SRS2’, indicating that this preparation might be superior to the 
other two.  
 
Detection and quantification of parasitaemia (II, III, IV) 
To further evaluate the different iscom formulations, a series of challenge 
experiment was performed. The parameters used to assess resistance against 
infection were clinical symptoms, including changes in body weight, and the 
amount of parasite DNA detected in the brain three weeks after infection (II, III). 
For this purpose a real-time PCR was developed to detect N. caninum DNA (III). 
Study  IV assessed if this assay was sensitive enough to detect and quantify 
parasitaemia in mice after infection, for evaluation of protective immunity. 
 
In a first experiment, three groups of 12 mice were inoculated with 5x10
6 
(Group 1), 10
6 (Group 2) or 10
5 (Group 3) live tachyzoites. As expected, clinical 
symptoms were observed in all of the inoculated mice, and the mice inoculated 
with the lowest dose were the least affected. Six mice in Group 1, three in Group 2 
and two in Group 3 showed severe symptoms, and were killed before the end of 
experiment. Analysis of blood samples collected every second day for 12 days, 
and thereafter with longer intervals, showed that N. caninum DNA could be 
detected most frequently from days 2 to 8 post inoculation, and thereafter only 
sporadically. This was consistent with a similar study, in which parasitaemia was 
detected in most inoculated mice on days 1 to 7 post inoculation and thereafter 
only intermittently (Collantes-Fernandez et al., 2006). 
 
In the present study, N. caninum DNA was detected in the brain from all 
inoculated mice, except three mice given the lowest number of tachyzoites. The 
levels of parasite DNA in the brain were significantly different between groups 
(P<0.01), with the lowest levels detected in the group inoculated with the lowest 
dose. Thus, the level of parasitaemia seemed to be correlated to the amount of 
parasite DNA in the brain and to disease severity. Results from other studies 
support a correlation between disease severity and parasite load in the brain 
(Collantes-Fernandez et al., 2006; Long, Baszler & Mathison, 1998). 
 
The results showed that the real-time PCR was sensitive, and could be used for 
detection and quantification the parasite DNA in the relative small blood volume   36
that can be collected from mice on multiple occasions. The real-time PCR had a 
detection limit at 0.008 pg N. caninum DNA, which is approximately equivalent to 
0.1 tachyzoite genome. Despite this, only a few of the samples from the groups 
inoculated with the lowest dose were positive. Thus, analysis of larger volumes of 
blood, or more frequent sampling, would be desirable to increase the probability of 
parasite DNA detection, but this is obviously difficult in the murine model. The 
results from this experiment were used to design the study of parasitaemia in 
immunised mice described below. A high infection dose was chosen, and blood 
was collected every day for nine days after infection. 
 
Protective effect of NcSRS2 iscoms (II, III, IV) 
In the first challenge experiment (II), BioSRS2´-iscom(Ni) was used to investigate 
whether the recombinant SRS2´ could induce protective immunity. After challenge 
infection, mice immunised with these SRS2´-iscoms exhibited only mild and 
transient symptoms. In contrast, the control mice immunised with M5-iscom(Ni) 
became progressively more affected, and some of them developed neurological 
symptoms. These mice started to lose weight from day 15 after infection, while the 
weights of mice given SRS2´-iscoms and of the uninfected controls remained at 
the same level until the end of the experiment. The differences in average weight 
change between the three groups were close to significant (P=0.051). However, 
the level of parasite DNA in the brains was significantly lower in immunised mice 
compared to the control mice (P<0.01). Moreover, while parasite DNA was 
detected in the brain of all mice in the infected control group, 3 of 10 mice 
immunised with this NcSRS2’-iscom formulation were negative. Taken together, 
these results clearly show that BioSRS2´-iscom(Ni) can induce immunity 
sufficient to reduce infection of the brain and disease severity. 
 
Thereafter, the protective effects of the three different SRS2´-iscom preparations 
[BioSRS2´-iscom(Ni) (Group 1), SA-SRS2´-iscom(Bio) (Group 2) and SA-SRS2´-
iscom(Ni) (Group 3)] were compared (III). Control mice were immunised with 
M5-iscoms (Group 4). After challenge infection, all immunised groups (Groups 1–
3) showed mild clinical signs for 7 days, and thereafter they appeared normal until 
the end of the experiment, except 4 out of the 10 mice in Groups 1 and 3 still 
remained mildly affected. The infected control mice (Group 4) developed obvious 
clinical symptoms, and became progressively more affected. 
 
In this experiment, the overall differences in average weight change between the 
groups were clearly statistically significant (P<0.001). Pairwise comparisons 
showed that the infected controls lost significantly more weight than did the mice 
in all of the immunised groups. In addition, the weight changes in Group 2 and in 
the uninfected control mice were not significantly different, whereas the mice in 
Groups 1 and 3 lost significantly more weight than did the uninfected controls. 
Moreover, the parasite DNA load in the brain was significantly different between 
groups  (P<0.001). Parasite DNA was detected in all infected control mice, 
whereas no parasite DNA could be detected in 1, 6 and 1 of the 10 immunised 
mice in Groups 1, 2 and 3, respectively.  37 
Thus, immunisation with all three SRS2´-iscom formulations induced immunity 
sufficient to reduce cerebral infection and clinical symptoms. Of the three 
formulations compared, SA-SRS2´-iscom(Bio) afforded the best protection. This 
was also the formulation giving the strongest antigen-specific cellular responses 
with the highest levels of IFN- production. Since the balance between Th1 and 
Th2 responses is considered to be important for resistance against N. caninum, the 
relationship between IFN- and IL-4 levels, and between IgG1 and IgG2a titres, 
induced by the different iscoms were compared, but no differences were found. 
Thus, the degree of protection seemed to be correlated to the strength of the 
cellular responses, rather than to differences in Th1/Th2 balance. 
 
In Paper IV, the protective effect of two of the SRS2´-iscoms was further 
evaluated, as regards reduction of parasitaemia after challenge infection. In this 
experiment, two groups of mice were immunised with either SA-SRS2´-
iscom(Bio) or SA-SRS2´-iscom(Ni). Analysis of blood samples collected daily 
during 9 days after challenge infection revealed significant differences in the 
concentration of N. caninum DNA between groups and over time (P<0.001 and 
P<0.01, respectively). Also, the duration of parasitaemia seemed to be shorter in 
immunised mice than in non-immunised infected mice, since parasite DNA was 
detected in at least three of the non-immunised mice on days 1 to 7 post 
inoculation, but in the immunised groups this number of mice were found positive 
only during the first 3 days.  
 
As in the previous experiments, the immunised mice showed mild clinical signs 
for some days after infection, and thereafter most of them recovered. However, 
some of them still showed mild signs of illness until the end of experiment, and 
two mice given SA-SRS2´-iscom(Bio) and one given SA-SRS2´-iscom(Ni) 
became worse and were killed on day 20 after infection. The non-immunised 
infected mice developed severe symptoms and 5 of the 18 mice had to be killed. 
They also lost significantly more weight (P<0.001) and had significantly more 
N. caninum DNA in their brains (P<0.001) than the immunised mice, but there 
was no significant difference between the two immunised groups. There appeared 
to be a good correlation between the degree of parasitaemia and the amount of 
parasite DNA in the brain 3 weeks after infection. 
 
The results from this study indicate that the immunised mice were able to control 
the infection during the early stage, which resulted in reduced parasitaemia. 
Similar results have been reported from a study of T. gondii infection, in which 
mice immunised with an attenuated strain had reduced parasitaemia after challenge 
infection (Kirisits et al. 2000). It is likely that the lower brain parasite load in 
immunised mice was a result of reduced parasitaemia and fewer parasites reaching 
the brain. 
 
The difference in protective effect of the two formulations SA-SRS2´-
iscom(Bio) and SA-SRS2´-iscom(Ni) that was recorded in the previous experiment 
(III) was not evident this time (IV). The reasons for this discrepancy could be that 
different batches of iscoms were used, variations in the virulence of the parasites, 
or individual mouse responses.   38
In conclusion, the present studies show that the bacterially expressed NcSRS2 
recombinant immunogen was successfully associated with iscom matrices by 
different approaches. It was found that the three different NcSRS2´ iscom 
preparations were capable of inducing antibody and cellular immune responses. 
Hence, immunised mice showed sufficient resistance to reduce the level and 
duration of parasitaemia, and the intensity of infection in the brain. In addition, 
both approaches of indirect and direct iscom association via biotin-streptavidin 
interaction are likely to constitute valuable means to achieve efficient iscom 
association of recombinant immunogens. 
 
The potential of NcSRS2 as a vaccine candidate 
Vaccination against neosporosis is a possible strategy for disease control. 
However, to design an effective vaccine against N. caninum infection is a 
challenge for vaccinologists. Several research groups have evaluated different 
immunodominant proteins associated with different adjuvant systems in 
experimental vaccines, and partial protective immunity has been achieved in 
mouse experiments. However, comparison of the degree of protection obtained in 
different experiments is difficulty because of dissimilarities of certain 
circumstances; e.g. antigen/immunogen used, (laboratory) animal species and 
strains, immunisation dose, administration route, the parasite isolate and number of 
parasites used for challenge infection, and finally the parameters and methods used 
for evaluation of the protective immunity. 
 
A number of N. caninum antigens have been considered as vaccine candidates. 
Many of them are immunodominant and/or have been shown to be functionally 
involved in different phases of the infection process (i.e. play a crucial role in 
infection). Some of them have been evaluated in vaccination trials, either as 
recombinant subunit, as DNA vaccines or expressed by live vectors. For example, 
live recombinant vectors expressing NcSAG1 or NcSRS2 (Nishikawa et al., 
2001b), recombinant NcSAG1 or NcSRS2 alone or after priming with cDNA 
(Cannas et al., 2003a), NcMIC1 (Alaeddine et al., 2005), NcMIC3 (Cannas et al., 
2003b), NcGRA7 (Jenkins et al., 2004; Liddell et al., 2003), and NcDG1 and 
NcDG2 (Cho et al., 2005) have been studied. In most of these experiments partial 
protection was observed. 
 
Among these antigens, NcSRS2, the major immunodominant surface antigen 
found in both tachyzoites and bradyzoites, has been considered as a potential 
antigen in future vaccines (Fuchs et al., 1998; Hemphill & Gottstein, 1996; Howe 
et al., 1998). In the present studies, it was shown that the E. coli-expressed 
recombinant NcSRS2 in different iscom formulations gave partial protection 
against clinical disease and significant reduction in brain parasite load (II, III, IV). 
Similar protective effects have been demonstrated after priming with cDNA 
coding for NcSRS2 and boosting with the recombinant protein (Cannas, et al., 
2003a). Immunisation with NcSRS2 constructed in a live vector has been shown 
both to reduce infection in non-pregnant mice (Nishikawa et al., 2001a) and to 
prevent transplacental transmission (Nishikawa et al., 2001b). Affinity-purified  39 
native NcSRS2 has also been shown to reduced transplacental transmission 
(Haldorson et al., 2005). Furthermore, the selection of antigens recognised by 
specific antibodies and immune T cells might be useful to identify candidate 
antigens. Recently, it has been reported that NcSRS2, rather than NcSAG1, could 
induced activation of memory CD4
+ and CD8
+ T lymphocytes from 
experimentally infected cattle (Staska et al., 2005). 
 
In conclusion, NcSRS2 seems to be a promising candidate antigen for a vaccine 
against neosporosis (i.e. that can elicit elements of potentially protective immune 
responses against the infection). However, the partial protection induced so far by 
the various experimental NcSRS2 vaccines needs to be improved. This might be 
achieved by improvement of recombinant protein conformation, optimisation of 
the adjuvants used, or selection of other delivery adjuvant systems. Another 
strategy that should be considered is to use a combination of different recombinant 
antigens, to enable the induction of complete protection. 
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Conclusions 
Efficient association of recombinant immunogens to iscoms was achieved by a 
novel method taking advantage of the strong biospecific interaction between biotin 
and streptavidin. This was achieved either by indirect binding of biotinylated 
proteins to Ni
2+-loaded matrix via His6-SA or by direct binding of streptavidin-
fusion proteins to biotinylated iscom matrix. 
 
Since many recombinant proteins are hydrophilic, they need an appropriate 
modification in order to become efficiently associated to the adjuvant.  The 
approaches described might offer convenient and effective methods to achieve 
iscom association of various recombinant antigens for development of the new 
generation of adjuvant-subunit vaccines.  
 
Mice immunised with bacterially expressed NcSRS2 and associated with iscoms 
according to the two described concepts induced promising humoral and cellular 
immune responses. The immunisation resulted in production of specific antibodies 
that reacted with the native N. caninum antigen, and the recombinant antigens 
were recognised by polyclonal and monoclonal antibodies raised to N. caninum. 
Therefore, it was concluded that the conformation of the recombinant proteins 
were similar to that of the native protein. Furthermore, immunisation with  the 
NcSRS2-iscoms generated an antigen-specific cellular response including 
production of IFN- and IL-4. 
 
The real-time PCR assay based on the detection of the Nc-5 repeated sequence 
of N. caninum was found to be a sensitive means for rapid quantitative detection of 
N. caninum DNA in blood and brain samples from infected mice. 
 
It was demonstrated that in murine neosporosis the level of parasitaemia during 
the acute stage of infection appeared to be correlated to disease severity and the 
amount of parasites in the brain during the chronic stage. 
 
The recombinant NcSRS2-iscoms induced partial protection against challenge 
infection, which was demonstrated as reduced clinical symptoms, brain parasite 
load and parasitaemia. Although comparison of the protective effect of the 
different iscom formulations was not conclusive as regards which of them was 
best, it showed that protection seemed to be associated with efficient induction of 
cellular responses. 
 
The recombinant NcSRS2 is a potential candidate antigen for a future vaccine 
against neosporosis. However, such a vaccine should probably contain a 
combination of different protective antigens to be able to induce complete 
protection. 
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